Cranberry Proanthocyanidins for Modification of Intestinal E. Coli Flora and Prevention of Urinary Tract Infections in UTI-Susceptible Women

NCT01219595 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 65

Last updated 2016-01-29

No results posted yet for this study

Summary

The purpose of the research is to determine if eating sweetened, dried cranberries or strawberry fruit pieces will increase the types of different E. coli bacteria in the intestines which may reduce the likelihood of a major, or highly harmful urinary type of bacteria which cause urinary tract infections in susceptible women.

Conditions

Interventions

OTHER

Sweetened, dried cranberries

Women in Arm 1 will consume one serving (1/3 cup; 42 g) of sweetened, dried cranberries each day for two weeks.

OTHER

Strawberry Fruit Pieces

1 serving (1/3 cup; 42 g) of strawberry fruit pieces each day for three separate, two-week periods. Each two week period will be separated by a two-week interval.

OTHER

Sweetened, dried cranberries

1 serving (1/3 cup; 42 g) of sweetened, dried cranberries each day for three separate, two-week periods. Each two week period will be separated by a two-week interval.

OTHER

Sweetened, dried cranberries

1 serving (1/3 cup; 42 g) of sweetened, dried cranberries each day for one 4-week period.

OTHER

Strawberry Fruit Pieces

1 serving (1/3 cup; 42 g) of strawberry fruit pieces each day for one 4-week period.

OTHER

Observation

Subjects in the non-UTI susceptible group will have one visit where one vaginal and one rectal swab will be collected.

Sponsors & Collaborators

  • Ocean Spray Cranberries, Inc.

    collaborator INDUSTRY
  • University of Wisconsin, Madison

    lead OTHER

Principal Investigators

  • Walter Hopkins, PhD · University of Wisconsin, Madison

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01219595 on ClinicalTrials.gov